Maywufa Co Ltd Asset Resilience Ratio
Maywufa Co Ltd asset resilience ratio. Maywufa Co Ltd (1731) has an Asset Resilience Ratio of 12.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Maywufa Co Ltd (1731) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Maywufa Co Ltd (2002–2024)
Asset resilience ratio of Maywufa Co Ltd from 2002 to 2024. This chart shows how Maywufa Co Ltd's Asset Resilience Ratio has changed over time. Read Maywufa Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Maywufa Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 1731 asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$396.63 Million | 12.77% |
| Total Liquid Assets | NT$396.63 Million | 12.77% |
Asset Resilience Insights
- Moderate Liquidity: Maywufa Co Ltd has 12.77% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Maywufa Co Ltd Industry Peers by Asset Resilience Ratio
Compare Maywufa Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Maywufa Co Ltd Asset Resilience Ratio by Year (2002–2024)
Maywufa Co Ltd asset resilience ratio by year from 2002 to 2024. The table below shows the annual Asset Resilience Ratio data for Maywufa Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 13.53% | NT$430.12 Million ≈ $13.55 Million |
NT$3.18 Billion ≈ $100.13 Million |
-0.42pp |
| 2023-12-31 | 13.95% | NT$395.13 Million ≈ $12.45 Million |
NT$2.83 Billion ≈ $89.23 Million |
-2.13pp |
| 2022-12-31 | 16.08% | NT$406.87 Million ≈ $12.82 Million |
NT$2.53 Billion ≈ $79.71 Million |
-7.75pp |
| 2021-12-31 | 23.83% | NT$641.66 Million ≈ $20.22 Million |
NT$2.69 Billion ≈ $84.83 Million |
+3.46pp |
| 2020-12-31 | 20.37% | NT$504.51 Million ≈ $15.89 Million |
NT$2.48 Billion ≈ $78.02 Million |
-0.16pp |
| 2019-12-31 | 20.54% | NT$561.76 Million ≈ $17.70 Million |
NT$2.74 Billion ≈ $86.17 Million |
+19.12pp |
| 2018-12-31 | 1.42% | NT$38.01 Million ≈ $1.20 Million |
NT$2.67 Billion ≈ $84.21 Million |
+0.48pp |
| 2017-12-31 | 0.94% | NT$25.00 Million ≈ $787.67K |
NT$2.65 Billion ≈ $83.50 Million |
-0.71pp |
| 2016-12-31 | 1.66% | NT$43.01 Million ≈ $1.35 Million |
NT$2.60 Billion ≈ $81.84 Million |
+0.44pp |
| 2015-12-31 | 1.22% | NT$32.00 Million ≈ $1.01 Million |
NT$2.63 Billion ≈ $82.86 Million |
-8.65pp |
| 2014-12-31 | 9.87% | NT$248.56 Million ≈ $7.83 Million |
NT$2.52 Billion ≈ $79.38 Million |
-4.86pp |
| 2013-12-31 | 14.73% | NT$377.46 Million ≈ $11.89 Million |
NT$2.56 Billion ≈ $80.74 Million |
+10.13pp |
| 2012-12-31 | 4.59% | NT$114.90 Million ≈ $3.62 Million |
NT$2.50 Billion ≈ $78.79 Million |
-7.51pp |
| 2011-12-31 | 12.10% | NT$297.44 Million ≈ $9.37 Million |
NT$2.46 Billion ≈ $77.43 Million |
-7.05pp |
| 2010-12-31 | 19.15% | NT$544.90 Million ≈ $17.17 Million |
NT$2.84 Billion ≈ $89.63 Million |
-2.56pp |
| 2009-12-31 | 21.72% | NT$613.20 Million ≈ $19.32 Million |
NT$2.82 Billion ≈ $88.96 Million |
+1.03pp |
| 2008-12-31 | 20.69% | NT$542.13 Million ≈ $17.08 Million |
NT$2.62 Billion ≈ $82.57 Million |
+13.53pp |
| 2007-12-31 | 7.16% | NT$225.82 Million ≈ $7.11 Million |
NT$3.15 Billion ≈ $99.39 Million |
+3.14pp |
| 2004-12-31 | 4.02% | NT$118.61 Million ≈ $3.74 Million |
NT$2.95 Billion ≈ $92.99 Million |
+0.11pp |
| 2003-12-31 | 3.91% | NT$95.59 Million ≈ $3.01 Million |
NT$2.45 Billion ≈ $77.05 Million |
+0.33pp |
| 2002-12-31 | 3.57% | NT$86.02 Million ≈ $2.71 Million |
NT$2.41 Billion ≈ $75.83 Million |
-- |
About Maywufa Co Ltd
Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. The company engages in the manufacturing, processing, and distribution of hairdressing products, soap, and cosmetics; distribution, wholesale, and retail trading of various beauty products, health products, and sports equipment; retail and wholesale business of health food, such as vitamin p… Read more